Ad is loading...
BVS
Price
$11.24
Change
+$0.11 (+0.99%)
Updated
Nov 15 closing price
123 days until earnings call
CORBF
Price
$1.30
Change
+$0.05 (+4.00%)
Updated
Nov 15 closing price
Ad is loading...

BVS vs CORBF

Header iconBVS vs CORBF Comparison
Open Charts BVS vs CORBFBanner chart's image
Bioventus
Price$11.24
Change+$0.11 (+0.99%)
Volume$278.28K
CapitalizationN/A
Global Cord Blood
Price$1.30
Change+$0.05 (+4.00%)
Volume$1.4K
CapitalizationN/A
BVS vs CORBF Comparison Chart
Loading...
BVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BVS vs. CORBF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVS is a StrongSell and CORBF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BVS: $11.24 vs. CORBF: $1.30)
Brand notoriety: BVS and CORBF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BVS: 58% vs. CORBF: 38%
Market capitalization -- BVS: $330.84M vs. CORBF: $154M
BVS [@Medical Specialties] is valued at $330.84M. CORBF’s [@Medical Specialties] market capitalization is $154M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVS’s FA Score shows that 0 FA rating(s) are green whileCORBF’s FA Score has 0 green FA rating(s).

  • BVS’s FA Score: 0 green, 5 red.
  • CORBF’s FA Score: 0 green, 5 red.
According to our system of comparison, CORBF is a better buy in the long-term than BVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVS’s TA Score shows that 4 TA indicator(s) are bullish.

  • BVS’s TA Score: 4 bullish, 6 bearish.

Price Growth

BVS (@Medical Specialties) experienced а -4.91% price change this week, while CORBF (@Medical Specialties) price change was +4.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

BVS is expected to report earnings on Mar 20, 2025.

CORBF is expected to report earnings on Feb 27, 2023.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BVS($331M) has a higher market cap than CORBF($154M). BVS has higher P/E ratio than CORBF: BVS (10.66) vs CORBF (1.99). BVS YTD gains are higher at: 113.283 vs. CORBF (6.557).
BVSCORBFBVS / CORBF
Capitalization331M154M215%
EBITDA-23.07MN/A-
Gain YTD113.2836.5571,728%
P/E Ratio10.661.99537%
Revenue512MN/A-
Total Cash37MN/A-
Total Debt395MN/A-
FUNDAMENTALS RATINGS
CORBF: Fundamental Ratings
CORBF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
62
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
38
SEASONALITY SCORE
1..100
22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BVS
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
BVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARDX4.970.26
+5.52%
Ardelyx
IMO73.98-0.64
-0.86%
Imperial Oil Limited
NCTY11.14-0.16
-1.42%
The9 Limited
DM4.50-0.08
-1.75%
Desktop Metal
ADMA19.04-1.16
-5.74%
ADMA Biologics

BVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BVS has been loosely correlated with RDNT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BVS jumps, then RDNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVS
1D Price
Change %
BVS100%
+0.99%
RDNT - BVS
37%
Loosely correlated
-1.83%
TCMD - BVS
36%
Loosely correlated
+0.19%
OFIX - BVS
35%
Loosely correlated
+2.73%
AORT - BVS
33%
Loosely correlated
-1.26%
NOTV - BVS
28%
Poorly correlated
-1.83%
More

CORBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORBF has been loosely correlated with SINT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CORBF jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORBF
1D Price
Change %
CORBF100%
+4.00%
SINT - CORBF
38%
Loosely correlated
-6.85%
APYX - CORBF
36%
Loosely correlated
-2.33%
MBOT - CORBF
33%
Loosely correlated
-2.43%
QTRX - CORBF
30%
Poorly correlated
-4.03%
BVS - CORBF
30%
Poorly correlated
+0.99%
More